6 completed, 1 unknown. 3 Phase 1, 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Unknown 1 |
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow VaxGen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers LC16m8 Smallpox Vaccine - Smallpox | Phase 1 / Phase 2 | Unknown | VaxGen | 150 | 2004-10-01 | 2007-01-15 |
| Trial of rPA-102 Vaccine in Healthy Adult Volunteers rPA102 - Anthrax | Phase 2 | Completed | VaxGen | 480 | 2004-04-01 | 2006-01-12 |
| HIV Vaccine Trial in Thai Adults ALVAC-HIV vCP1521 + AIDSVAX, ALVAC Placebo + AIDSVAX Placebo - HIV Infection | Phase 3 | Completed | U.S. Army Medical Research and Development Command | 16402 | 2003-10-01 | 2019-04-24 |
| Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine rPA102 Vaccine - Prevention of Anthrax Infection | Phase 1 | Completed | VaxGen | 100 | 2003-06-01 | 2005-06-24 |
| Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand MN rgp120/HIV-1 and A244 rgp120/HIV-1 - HIV Infections, HIV Seronegativity | Phase 3 | Completed | VaxGen | 2500 | 1999-03-01 | 2005-06-24 |
| Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection MN rgp120/HIV-1 and GNE8 rgp120/HIV-1 - HIV Infections, HIV Seronegativity | Phase 3 | Completed | VaxGen | 5000 | 2005-06-24 | |
| A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines MN rgp120/HIV-1 and GNE8 rgp120/HIV-1, MN rgp120/HIV-1 and A244 rgp120/HIV-1, Aluminum hydroxide - HIV Infections | Phase 1 | Completed | VaxGen | 120 | 2005-06-24 |
HIV Infections (4) · Acquired Immunodeficiency Syndrome (2) · Anthrax (1) · Sexually Transmitted Diseases (1) · Smallpox (1) · Substance Abuse, Intravenous (1)
AIDSVAX (1) · Aluminum Hydroxide (1) · smallpox vaccine LC16m8 (1)
United States (5) · Thailand (2) · Canada (1) · Netherlands (1) · Puerto Rico (1)
Kachit Choopanya (1) · Marc Gurwith, MD, JD (1) · Supachai Rerks-Ngarm, MD (1)
PMID 19149819, PMID 19843557, PMID 20079620, PMID 21921208, PMID 22205930, PMID 24504509, PMID 24829343, PMID 25350851, PMID 28131393, PMID 29702672, PMID 31999736, PMID 37256916, PMID 40190112